<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02786953</url>
  </required_header>
  <id_info>
    <org_study_id>151271</org_study_id>
    <nct_id>NCT02786953</nct_id>
  </id_info>
  <brief_title>Sleep Promotion to Improve Diabetes Management in Adolescents With T1D</brief_title>
  <official_title>Sleep Coach: Sleep Promotion to Improve Diabetes Management in Adolescents With T1D</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adolescents with type 1 diabetes (T1D) are at increased risk for problems with adherence and
      suboptimal glycemic control, and novel approaches are needed to improve outcomes in this
      high-risk population. The majority of adolescents obtain insufficient sleep (defined as &lt;8
      hours/night), and sleep disturbance has been significantly associated with poorer adherence
      and predicted greater problems with quality of life and worse glycemic control. Yet, no
      interventions have addressed sleep in youth with T1D. Working from a biopsychosocial and
      contextual model of sleep, the investigators propose to tailor a sleep-promoting intervention
      to meet the needs of adolescents with T1D by conducting interviews with to identify the
      barriers and facilitators to adequate sleep specific to this population. The sleep-promoting
      intervention will be developed and tested, building on successful sleep interventions in
      other populations, including components such as limiting caffeine, establishing a media
      curfew, and positive bedtime routines, while addressing the needs unique to adolescents with
      T1D, such as fear of hypoglycemia. The study will be conducted by a multidisciplinary team,
      consisting of Sarah Jaser, PhD, a pediatric psychologist, and two co-investigators, Beth
      Malow, MD, MS, a neurologist with specialty in sleep medicine, and Jill Simmons, MD, a
      pediatric endocrinologist. Sleep is a potentially modifiable risk factor that may have both a
      physiological and behavioral impact on diabetes outcomes. Given the strong associations
      between sleep and diabetes outcomes in the preliminary data, and recent evidence from sleep
      restriction studies indicating the impact of insufficient sleep on insulin sensitivity,
      behavior, and mood, there is reason to believe that a sleep-promoting intervention has the
      potential to improve outcomes in adolescents with T1D indirectly by improving adherence and
      directly through its effect on metabolic function. Therefore, the proposed study offers a
      novel approach to improve adherence, quality of life, and glycemic control in adolescents
      with T1D.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Working from a biopsychosocial and contextual model of sleep, this study will pilot test a
      sleep-promoting intervention tailored to meet the needs of adolescents with T1D, building on
      successful sleep interventions in other populations, including components such as limiting
      caffeine, establishing a media curfew, and positive bedtime routines, while addressing the
      needs unique to adolescents with T1D, such as fear of hypoglycemia. The study will be
      conducted by a multidisciplinary team, consisting of Sarah Jaser, PhD, a pediatric
      psychologist, and two co-investigators, Beth Malow, MD, MS, a neurologist with specialty in
      sleep medicine, and Jill Simmons, MD, a pediatric endocrinologist. Sleep is a potentially
      modifiable risk factor that may have both a physiological and behavioral impact on diabetes
      outcomes. Given the strong associations between sleep and diabetes outcomes in the
      preliminary data, and recent evidence from sleep restriction studies indicating the impact of
      insufficient sleep on insulin sensitivity, behavior, and mood, there is reason to believe
      that a sleep-promoting intervention has the potential to improve outcomes in adolescents with
      T1D indirectly by improving adherence and directly through its effect on metabolic function.
      Therefore, the proposed study offers a novel approach to improve adherence, quality of life,
      and glycemic control in adolescents with T1D.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 19, 2017</start_date>
  <completion_date type="Actual">February 5, 2019</completion_date>
  <primary_completion_date type="Actual">October 23, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sleep Quality: Baseline</measure>
    <time_frame>baseline</time_frame>
    <description>Sleep quality will be measured with the Pittsburgh Sleep Quality Index total score. Each of the sleep components yields a score ranging from 0 to 3, with 3 indicating the greatest dysfunction. The sleep component scores are summed to yield a total score ranging from 0 to 21 with the higher total score (referred to as global score) indicating worse sleep quality.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sleep Quality 3 Months</measure>
    <time_frame>3 months</time_frame>
    <description>Sleep quality will be measured with the Pittsburgh Sleep Quality Index total score. Each of the sleep components yields a score ranging from 0 to 3, with 3 indicating the greatest dysfunction. The sleep component scores are summed to yield a total score ranging from 0 to 21 with the higher total score (referred to as global score) indicating worse sleep quality.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Glycemic Control (HbA1c) Baseline</measure>
    <time_frame>Baseline</time_frame>
    <description>HbA1C is a measure of average blood glucose levels. It is measured quarterly at regular clinic visits.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Glycemic Control (HbA1c) 3 or 6 Months</measure>
    <time_frame>3 months or 6 months</time_frame>
    <description>HbA1C is a measure of average blood glucose levels. It is measured quarterly at regular clinic visits.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sleep Duration: Baseline</measure>
    <time_frame>baseline</time_frame>
    <description>Sleep duration will be measured with actigraphy (total sleep time)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sleep Duration: 3 Months</measure>
    <time_frame>3 months</time_frame>
    <description>Sleep duration will be measured with actigraphy (total sleep time)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life (PedsQL)</measure>
    <time_frame>Baseline and 3 months</time_frame>
    <description>The PedsQL, Type 1 Diabetes module, a self-report measure of quality of life will be used. Scaled scores range from 0-100, and higher scores indicate better quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adherence (Self Care Inventory) Parent</measure>
    <time_frame>Baseline and 3 months</time_frame>
    <description>The parent versions of the Self Care Inventory will be used to measure adherence to the diabetes treatment regimen. Mean scores are calculated, ranging from 1-5, with higher scores indicating better adherence.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adherence (Self Care Inventory) Teen</measure>
    <time_frame>Baseline and 3 months</time_frame>
    <description>The teen versions of the Self Care Inventory will be used to measure adherence to the diabetes treatment regimen. Mean scores are calculated, ranging from 1-5, with higher scores indicating better adherence.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Diabetes Mellitus, Type 1</condition>
  <arm_group>
    <arm_group_label>Sleep Promotion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Behavioral sleep-promoting intervention, including components such as limiting caffeine, establishing a media curfew, and positive bedtime routines, as well as needs unique to adolescents with T1D, such as fear of hypoglycemia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual Care</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Sleep Promotion</intervention_name>
    <description>Behavioral intervention to improve sleep quality and duration.</description>
    <arm_group_label>Sleep Promotion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed with type 1 diabetes for at least 12 months

          -  Speak and read English

          -  Report Insufficient sleep (&lt; 8 hours/night most school nights)

        Exclusion Criteria:

          -  Other major health problems or sleep disorders (other than insomnia)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sarah S Jaser, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>May 18, 2016</study_first_submitted>
  <study_first_submitted_qc>May 25, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 1, 2016</study_first_posted>
  <results_first_submitted>September 16, 2019</results_first_submitted>
  <results_first_submitted_qc>October 17, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">October 18, 2019</results_first_posted>
  <last_update_submitted>January 6, 2020</last_update_submitted>
  <last_update_submitted_qc>January 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University Medical Center</investigator_affiliation>
    <investigator_full_name>Sarah Jaser</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Sleep</keyword>
  <keyword>Adherence</keyword>
  <keyword>Diabetes Management</keyword>
  <keyword>Adolescent</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 20, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/53/NCT02786953/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>1 participant consented, completed baseline data, then withdrew</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Sleep Promotion</title>
          <description>Behavioral sleep-promoting intervention, including components such as limiting caffeine, establishing a media curfew, and positive bedtime routines, as well as needs unique to adolescents with T1D, such as fear of hypoglycemia.
Sleep Promotion: Behavioral intervention to improve sleep quality and duration.</description>
        </group>
        <group group_id="P2">
          <title>Usual Care</title>
          <description>Usual Care</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Baseline Teen Survey Data Completed</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="18">One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>Baseline Parent Survey Completed</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="18">One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>Actigraph Data Complete</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="17">One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>A1C Data Baseline</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="18">One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>Session 1 Completed</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Session 2 Completed</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Session 3 Completed</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>3 Month Teen Survey Completed</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>3 Month Parent Survey Completed</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>A1C 3 Month</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>1 family enrolled and was randomized to usual care. Teen was diagnosed with a condition that caused them to be excluded, so they were removed from baseline analysis.</population>
      <group_list>
        <group group_id="B1">
          <title>Sleep Promotion</title>
          <description>Behavioral sleep-promoting intervention, including components such as limiting caffeine, establishing a media curfew, and positive bedtime routines, as well as needs unique to adolescents with T1D, such as fear of hypoglycemia.
Sleep Promotion: Behavioral intervention to improve sleep quality and duration.</description>
        </group>
        <group group_id="B2">
          <title>Usual Care</title>
          <description>Usual Care</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="18"/>
            <count group_id="B3" value="38"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14.85" spread="1.27"/>
                    <measurement group_id="B2" value="15.72" spread="1.32"/>
                    <measurement group_id="B3" value="15.26" spread="1.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>White, Non-Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Annual Income</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>&lt;$39,999</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>$40,000-$79,999</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;$80,000</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Missing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Treatment Type</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Insulin Pump</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Injection</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Sleep Quality: Baseline</title>
        <description>Sleep quality will be measured with the Pittsburgh Sleep Quality Index total score. Each of the sleep components yields a score ranging from 0 to 3, with 3 indicating the greatest dysfunction. The sleep component scores are summed to yield a total score ranging from 0 to 21 with the higher total score (referred to as global score) indicating worse sleep quality.</description>
        <time_frame>baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sleep Promotion</title>
            <description>Behavioral sleep-promoting intervention, including components such as limiting caffeine, establishing a media curfew, and positive bedtime routines, as well as needs unique to adolescents with T1D, such as fear of hypoglycemia.
Sleep Promotion: Behavioral intervention to improve sleep quality and duration.</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Usual Care</description>
          </group>
        </group_list>
        <measure>
          <title>Sleep Quality: Baseline</title>
          <description>Sleep quality will be measured with the Pittsburgh Sleep Quality Index total score. Each of the sleep components yields a score ranging from 0 to 3, with 3 indicating the greatest dysfunction. The sleep component scores are summed to yield a total score ranging from 0 to 21 with the higher total score (referred to as global score) indicating worse sleep quality.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.3" spread="1.7"/>
                    <measurement group_id="O2" value="4.5" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Sleep Quality 3 Months</title>
        <description>Sleep quality will be measured with the Pittsburgh Sleep Quality Index total score. Each of the sleep components yields a score ranging from 0 to 3, with 3 indicating the greatest dysfunction. The sleep component scores are summed to yield a total score ranging from 0 to 21 with the higher total score (referred to as global score) indicating worse sleep quality.</description>
        <time_frame>3 months</time_frame>
        <population>includes only participants with baseline and 3 month data</population>
        <group_list>
          <group group_id="O1">
            <title>Sleep Promotion</title>
            <description>Behavioral sleep-promoting intervention, including components such as limiting caffeine, establishing a media curfew, and positive bedtime routines, as well as needs unique to adolescents with T1D, such as fear of hypoglycemia.
Sleep Promotion: Behavioral intervention to improve sleep quality and duration.</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Usual Care</description>
          </group>
        </group_list>
        <measure>
          <title>Sleep Quality 3 Months</title>
          <description>Sleep quality will be measured with the Pittsburgh Sleep Quality Index total score. Each of the sleep components yields a score ranging from 0 to 3, with 3 indicating the greatest dysfunction. The sleep component scores are summed to yield a total score ranging from 0 to 21 with the higher total score (referred to as global score) indicating worse sleep quality.</description>
          <population>includes only participants with baseline and 3 month data</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.9" spread="1.5"/>
                    <measurement group_id="O2" value="4.8" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Glycemic Control (HbA1c) Baseline</title>
        <description>HbA1C is a measure of average blood glucose levels. It is measured quarterly at regular clinic visits.</description>
        <time_frame>Baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sleep Promotion</title>
            <description>Behavioral sleep-promoting intervention, including components such as limiting caffeine, establishing a media curfew, and positive bedtime routines, as well as needs unique to adolescents with T1D, such as fear of hypoglycemia.
Sleep Promotion: Behavioral intervention to improve sleep quality and duration.</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Usual Care</description>
          </group>
        </group_list>
        <measure>
          <title>Glycemic Control (HbA1c) Baseline</title>
          <description>HbA1C is a measure of average blood glucose levels. It is measured quarterly at regular clinic visits.</description>
          <units>percentage of glycosylated Hgb</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.4" spread="2.2"/>
                    <measurement group_id="O2" value="9.1" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Glycemic Control (HbA1c) 3 or 6 Months</title>
        <description>HbA1C is a measure of average blood glucose levels. It is measured quarterly at regular clinic visits.</description>
        <time_frame>3 months or 6 months</time_frame>
        <population>Some participants missed the 3 month appointment, so the final result is a combination of 3 month and 6 month values</population>
        <group_list>
          <group group_id="O1">
            <title>Sleep Promotion</title>
            <description>Behavioral sleep-promoting intervention, including components such as limiting caffeine, establishing a media curfew, and positive bedtime routines, as well as needs unique to adolescents with T1D, such as fear of hypoglycemia.
Sleep Promotion: Behavioral intervention to improve sleep quality and duration.</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Usual Care</description>
          </group>
        </group_list>
        <measure>
          <title>Glycemic Control (HbA1c) 3 or 6 Months</title>
          <description>HbA1C is a measure of average blood glucose levels. It is measured quarterly at regular clinic visits.</description>
          <population>Some participants missed the 3 month appointment, so the final result is a combination of 3 month and 6 month values</population>
          <units>percentage of glycosylated Hemoglobin</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.2" spread="2.0"/>
                    <measurement group_id="O2" value="9.2" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Sleep Duration: Baseline</title>
        <description>Sleep duration will be measured with actigraphy (total sleep time)</description>
        <time_frame>baseline</time_frame>
        <population>only participants with usable actigraph data</population>
        <group_list>
          <group group_id="O1">
            <title>Sleep Promotion</title>
            <description>Behavioral sleep-promoting intervention, including components such as limiting caffeine, establishing a media curfew, and positive bedtime routines, as well as needs unique to adolescents with T1D, such as fear of hypoglycemia.
Sleep Promotion: Behavioral intervention to improve sleep quality and duration.</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Usual Care</description>
          </group>
        </group_list>
        <measure>
          <title>Sleep Duration: Baseline</title>
          <description>Sleep duration will be measured with actigraphy (total sleep time)</description>
          <population>only participants with usable actigraph data</population>
          <units>hours</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.85" spread="0.82"/>
                    <measurement group_id="O2" value="6.69" spread="1.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Sleep Duration: 3 Months</title>
        <description>Sleep duration will be measured with actigraphy (total sleep time)</description>
        <time_frame>3 months</time_frame>
        <population>only participants with usable actigraph data</population>
        <group_list>
          <group group_id="O1">
            <title>Sleep Promotion</title>
            <description>Behavioral sleep-promoting intervention, including components such as limiting caffeine, establishing a media curfew, and positive bedtime routines, as well as needs unique to adolescents with T1D, such as fear of hypoglycemia.
Sleep Promotion: Behavioral intervention to improve sleep quality and duration.</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Usual Care</description>
          </group>
        </group_list>
        <measure>
          <title>Sleep Duration: 3 Months</title>
          <description>Sleep duration will be measured with actigraphy (total sleep time)</description>
          <population>only participants with usable actigraph data</population>
          <units>hours</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.02" spread="0.78"/>
                    <measurement group_id="O2" value="6.37" spread="0.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Quality of Life (PedsQL)</title>
        <description>The PedsQL, Type 1 Diabetes module, a self-report measure of quality of life will be used. Scaled scores range from 0-100, and higher scores indicate better quality of life.</description>
        <time_frame>Baseline and 3 months</time_frame>
        <population>only participants with both baseline and 3 month data</population>
        <group_list>
          <group group_id="O1">
            <title>Sleep Promotion</title>
            <description>Behavioral sleep-promoting intervention, including components such as limiting caffeine, establishing a media curfew, and positive bedtime routines, as well as needs unique to adolescents with T1D, such as fear of hypoglycemia.
Sleep Promotion: Behavioral intervention to improve sleep quality and duration.</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Usual Care</description>
          </group>
        </group_list>
        <measure>
          <title>Quality of Life (PedsQL)</title>
          <description>The PedsQL, Type 1 Diabetes module, a self-report measure of quality of life will be used. Scaled scores range from 0-100, and higher scores indicate better quality of life.</description>
          <population>only participants with both baseline and 3 month data</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70.3" spread="8.0"/>
                    <measurement group_id="O2" value="74.5" spread="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.5" spread="10.3"/>
                    <measurement group_id="O2" value="75.4" spread="9.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Adherence (Self Care Inventory) Parent</title>
        <description>The parent versions of the Self Care Inventory will be used to measure adherence to the diabetes treatment regimen. Mean scores are calculated, ranging from 1-5, with higher scores indicating better adherence.</description>
        <time_frame>Baseline and 3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sleep Promotion</title>
            <description>Behavioral sleep-promoting intervention, including components such as limiting caffeine, establishing a media curfew, and positive bedtime routines, as well as needs unique to adolescents with T1D, such as fear of hypoglycemia.
Sleep Promotion: Behavioral intervention to improve sleep quality and duration.</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Usual Care</description>
          </group>
        </group_list>
        <measure>
          <title>Adherence (Self Care Inventory) Parent</title>
          <description>The parent versions of the Self Care Inventory will be used to measure adherence to the diabetes treatment regimen. Mean scores are calculated, ranging from 1-5, with higher scores indicating better adherence.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.7" spread=".66"/>
                    <measurement group_id="O2" value="3.8" spread=".69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.8" spread=".84"/>
                    <measurement group_id="O2" value="3.7" spread=".73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Adherence (Self Care Inventory) Teen</title>
        <description>The teen versions of the Self Care Inventory will be used to measure adherence to the diabetes treatment regimen. Mean scores are calculated, ranging from 1-5, with higher scores indicating better adherence.</description>
        <time_frame>Baseline and 3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sleep Promotion</title>
            <description>Behavioral sleep-promoting intervention, including components such as limiting caffeine, establishing a media curfew, and positive bedtime routines, as well as needs unique to adolescents with T1D, such as fear of hypoglycemia.
Sleep Promotion: Behavioral intervention to improve sleep quality and duration.</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Usual Care</description>
          </group>
        </group_list>
        <measure>
          <title>Adherence (Self Care Inventory) Teen</title>
          <description>The teen versions of the Self Care Inventory will be used to measure adherence to the diabetes treatment regimen. Mean scores are calculated, ranging from 1-5, with higher scores indicating better adherence.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.9" spread=".76"/>
                    <measurement group_id="O2" value="3.7" spread=".79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.8" spread=".46"/>
                    <measurement group_id="O2" value="3.9" spread=".59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>baseline to 3 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Sleep Promotion</title>
          <description>Behavioral sleep-promoting intervention, including components such as limiting caffeine, establishing a media curfew, and positive bedtime routines, as well as needs unique to adolescents with T1D, such as fear of hypoglycemia.
Sleep Promotion: Behavioral intervention to improve sleep quality and duration.</description>
        </group>
        <group group_id="E2">
          <title>Usual Care</title>
          <description>Usual Care</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="19"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>pilot study with small sample size</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Sarah S Jaser</name_or_title>
      <organization>Vanderbilt University Medical Center</organization>
      <phone>6153436775</phone>
      <email>sarah.jaser@vumc.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

